Description
sachet release form
coated tablets
Packing
50 pcs
Indications
Iron deficiency anemia.
Iron deficiency.
Prophylactic use in pregnancy, lactation and in blood donors.
Use during pregnancy and lactation
Indication for use is an increased need for iron during pregnancy and lactation.
If necessary, the prescription of the drug should carefully study the instructions.
Composition
Each enteric-coated tablet, 20 mg contains:
Active ingredient:
Rabeprazole sodium 20 mg
Excipients:
Shellac glaze 45%
Charming red dye ( 129)
-butanol
Denatured ethanol
Titanium dioxide ( 171)
Propylene glycol
Isopropyl alcohol
Ammonium sulfate, 100% sulfate, ferrous, solution 28%, concentrated, 28% in an amount
equivalent to 100 mg of Fe2 + and 60 mg of ascorbic acid,
as well as: magnesium stearate,
povidone K-25,
polyethylene powder,
carbomer 934 P.
Shell contains:
hypromellose,
rrdklrd,
titanium dioxide
iron oxide yellow,
paraffin wax solid.
Dosage and Administration
Coated tablets are taken orally.
They can not be divided or chewed.
The tablet should be swallowed whole and washed down with at least half a glass of liquid. Adults and teenagers:
1 tablet 1-2 times a day. If necessary, patients with iron deficiency anemia, the dose can be increased to 3-4 tablets per day for two doses (morning and evening) for 3-4 months (until the iron depot in the body is replenished).
During pregnancy and lactation:
Prevention: 1 tablet per day.
Therapeutic dose: 1 tablet 2 times a day (morning and evening). Treatment should be continued until an optimal hemoglobin level is achieved. For further replenishment of the depot, you may need to continue taking the drug for another 2 months.
Side effects
Nausea, vomiting, abdominal pain, diarrhea, constipation.
The frequency of side effects from the gastrointestinal tract may increase with increasing doses from 100 to 400 mg. Rarely (<1/100) can the following side effects be observed: peptic ulcer of the esophagus, esophageal stenosis, allergic reactions (itching, rash), skin hyperthermia, headache, dizziness, weakness. Drug Interaction Durules may reduce the absorption of co-administered enoxacin, clodronate, grepafloxacin, levodopa, levofloxacin, methyldopa, penicillamine, tetracyclines, and thyroid hormones. Concomitant use of Sorbifer Durules and antacid preparations containing aluminum hydroxide and magnesium carbonate may reduce iron absorption. The maximum possible time interval should be maintained between taking Sorbifer Durules and any of these drugs. The recommended minimum interval between doses is 2 hours, except for tetracyclines, when the minimum interval should be 3 hours. Sorbifer Durules should not be combined with the following drugs: ciprofloxacin, doxycycline, norfloxacin and ofloxacin. Overdose Symptoms: abdominal pain, vomiting and diarrhea with admixture of blood, fatigue or weakness, hyperthermia, parasthesia, paleness of skin, cold sticky sweat, acidosis, weak pulse, decrease in blood pressure, heart pressure. In severe overdose, signs of peripheral circulatory collapse, coagulopathy, hyperthermia, hypoglycemia, liver damage, renal failure, muscle cramps and coma may occur after 6-12 hours. Treatment: In case of overdose, seek medical advice immediately. It is necessary to wash the stomach, inside the raw egg, milk (to bind iron ions in the gastrointestinal tract) injected with Deferoxamine. Symptomatic therapy. Storage conditions In a dry, dark place, at a temperature not exceeding 20 ° C. Expiration 3 years. pharmacy terms with prescription Dosage form Dosage form tablets
